Kwabena Krow Ampofo, MD
Disclosures: Grant or research support-Merck - 11/28/2022
I

3/16/2022

 

RESUME

KWABENA KROW AMPOFO

PERSONAL DATA

Birthplace:                             Accra, Ghana
Citizenship:                             USA

Office Address:              Division of Infectious Diseases

                                          Department of Pediatrics
                                          295 Chipeta Way

                                          Salt Lake City, UT 84108

Office phone:                            (801)581-6631

Fax:                                          (801)585-3789

Email:                                          krow.ampofo@hsc.utah.edu

EDUCATION

Graduate:             

Bachelors in Medicine, Bachelors in Surgery (M.B., Ch.B.)                                          

University of Ghana Medical School

Accra, Ghana

1986-1991

                                                       

Internship:             

Children’s Hospital of New Jersey at Newark Beth Israel Medical Center

Newark, New Jersey

1996 – 1997

 

Residency:             

Children’s Hospital of New Jersey at Newark Beth Israel Medical Center

Newark, New Jersey

1997 – 1999

 

Fellowship:             

New York Presbyterian Hospital,

Children’s Hospital of New York

Division of Pediatric Infectious Diseases

New York, New York

1999- 2002

 

BOARD CERTIFICATIONS

 

American Board of Pediatrics certification

1999 (Certification)

2006 (Recertification)

 

Pediatric Infectious Diseases certification

2003 (Certification and ongoing with MOC)

CURRENT LICENSES/CERTIFICATIONS

Utah Division of Occupational and Professional Licensing

2005 to date

 

DEA certificate

2005 to date

PROFESSIONAL EXPERIENCE

Professor

Pediatric Infectious Diseases

University of Utah School of Medicine

Salt Lake City, UT

July 2013 to date

Associate Professor

Pediatric Infectious Diseases

University of Utah School of Medicine

Salt Lake City, UT

July 2009 - June 2013.

Assistant Professor

Pediatric Infectious Diseases

University of Utah School of Medicine

Salt Lake City, UT

July 2003 - June 2009.

Visiting Instructor

Pediatric Infectious Diseases

University of Utah School of Medicine

Salt Lake City, UT

January 2003 – June 2003

 

Clinical Instructor

Pediatric Infectious Diseases

New York Presbyterian Hospital, Children’s Hospital of New York

New York, New York

July 2002- December 2002

 

Consultant

Tuberculosis Bureau

Utah Department of Health

Salt Lake City, UT

Clinical care and evaluation of patients with tuberculosis

January 2003 to date

 

International Adoption Clinic

University of Utah

Salt Lake City, UT

Clinical care and evaluation of internationally adopted children

January 2003 to date

 

ADMINISTRATIVE EXPERIENCE

Co-Director

Health Equity Research Core

Department of Pediatrics

University of Utah

2020

 

Project Co-lead (Utah COVID-19 School testing program)

The Utah Health and Economic Recovery (HERO) Project- School Project.

(https://eccles.utah.edu/utah-health-economic-recovery-outreach/)

University of Utah

2020

 

Fellowship Director                            

Global Pediatric Infectious Diseases Fellowship Program

University of Utah

2020

 

Completed the Intermountain Healthcare Advanced Training Program in               

Health Care Delivery Improvement and Research- Healthcare Patient Safety

Emphasis

2015

2020 (Refresher)

 

Fellowship Director                            

Pediatric Infectious Diseases Fellowship Program

University of Utah

2009 – 2012

 

Director

International Adoption Clinic

University of Utah

Clinical care and evaluation of internationally adopted children

2003 to date

 

 

Symposium/Meeting Chair/Coordinator

Moderator

Respiratory Infections in Children

Infectious Diseases Society of America

Boston, Massachusetts

2011

 

 

Editorial Experience

Clinical Infectious Diseases

2006 to date

 

Pediatric Infectious Disease Journal

2006 to date


Journal of Medical Microbiology

2006 to date

 

Pediatrics

2007 to date

 

American Association of Pediatrics Red Book

2008 to date

 

Vaccine

2011 to date

 

Journal of Pediatrics

2012 to date

 

Journal of Pediatrics Infectious Diseases Society

2012 to date

 

SCHOLASTIC HONORS

Pediatric intern of the year                                                                                                                1997

Pediatric Resident of the year                                                                                                                1999

University of Utah Pediatric Translational and Clinical Research Scholar                            2007

Primary Children’s Medical Center Foundation Scholar                                                        2007

Completed the Intermountain Healthcare Advanced Training Program in                2015

Health Care Delivery Improvement and Research- Healthcare Patient Safety

Emphasis

 

PROFESSIONAL COMMUNITY ACTIVITIES

IDSA Pediatric CAP guidelines Committee

2019-

 

IDSA's Adhoc Group on Global Brain Drain

2008 to 2009

UNIVERSITY COMMUNITY ACTIVITIES

Pediatric Grand Rounds Advisory Committee                                                                     

2005 - present

MEMBERSHIP IN PROFESSIONAL SOCIETIES

American Academy of Pediatrics- Fellow

Pediatric Infectious Disease Society- Fellow

Infectious Diseases Society of America- Fellow

Society for Pediatric Research- Member

 

FUNDING

 

Active Grants

 

2020

The Utah Health and Economic Recovery (HERO) Project- School Project.

(https://eccles.utah.edu/utah-health-economic-recovery-outreach/)

University of Utah

Role: Investigator

 

2019 – to date

Merck & Co. Inc

The Burden of Readmission Following RSV Hospitalization in Utah

Role: Principal investigator

 

2017 – 2022

NIH NATL INST ALLERGY & INFECTIOUS DIS

Grant # R01AI125642

Risk Stratification and Decision Support to Improve Care and Outcomes in Children with Pneumonia.

Role: Site principal investigator

 

2017 to date

NIH

Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants (ValEAR Trial); 

Role: Co- investigator

 

 

Past Grants

2017- 2020

Merck and Co. Inc

MK-6072: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of a Single Infusion of Bezlotoxumab (MK- 6072, Human Monoclonal Antibody to C. difficile Toxin B) in Children.

Role: Site principal investigator

 

2017 to 2020

Merck and Co., Inc

MK-7625A-035: A Phase 2, Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Efficacy of Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem in Pediatric Subjects with Complicated Intra-Abdominal Infection.

Role: Site principal investigator

 

2017 to 2021

Merck and Co., Inc

MK1986-014: A Phase 1, Single-Dose Safety and Pharmacokinetic Study of Oral and IV Tedizolid Phosphate (MK-1986) in Inpatients Under 2 Years Old, Merck and Co, Inc

Role: Site principal investigator

 

20142019

Fed Grant # - HHSD20002013M53890B

Epidemiology of Novel Influenza Virus Infection and Evaluation of Antiviral Effectiveness and Vaccine Effectiveness Against Influenza-Associated Hospitalization 

CDC/ National Center for Immunization and Respiratory Diseases

Role: Principal investigator

 

2011-2016

Fed Grant # - HHSN272201100034C

University of Alabama / NIH/NIAID

Identification of Herpes Simplex Virus (HSV) Shedding in the Female Genital Tract of Pregnant and Nonpregnant Women by the Xpert HSV 1/2 Assay, Routine PCR, and Culture.

Role: Site PI

 

2011-2016

Fed Grant # - HHSN272201100035C             

University of Alabama / NIH/NIAID

A Phase II Randomized And Controlled Investigation Of Six Weeks Of Oral Valganciclovir Therapy In Infants And Children With Congenital Cytomegalovirus Infection And Hearing Loss.

Role: Site PI

 

2012-2015

NAI113678

An Open-Label, Multi-Center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects with Confirmed Influenza Infection.

 

2013-2015

DAP-PEDOST-11-03

Cubist Pharmaceuticals, Inc.

A Multicenter, Randomized, Double-Blinded Comparative Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Daptomycin Versus Active Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis Due to Gram-Positive Organisms.

Role: Site PI

 

2011 – 2014

3U18IP000491-02S1 (Epidemiology and Etiology of Hospitalized Pneumonia in Children.

CDC/ National Center for Immunization and Respiratory Diseases

Role: Principal investigator

 

2007-2012

U01-AI74419-01 (HT-Film-Array: a system to assess respiratory viruses with emphasis on influenza).

Direct Costs

NIH/NIAID

Role: Co-Investigator

 

2009 – 2011

1U18IP000303 (Epidemiology and Etiology of Hospitalized Pneumonia in    Children (Phase I)).

Direct Costs

CDC/ National Center for Immunication and Respiratory Diseases

Role: Principal investigator

 

2007 2008

Upper respiratory tract viral infection and bacterial nasopharyngeal colonization

PCMC Foundation

Role: Principal investigator

 

NIAID/DMID Collaborative Antiviral Study Group A Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Oseltamivir (Tamiflu) for the Treatment of Children Less than 24 Months of Age with Confirmed Influenza Infection

Role: Co-Investigator

PI-Whitley, R, University of Alabama

2006 - 2009

 

Industry Sponsored (Novartis): A Randomized, Double-Blind, Placebo-controlled, Multicenter Phase 3 Trial to Assess the Efficacy and Safety of Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis (CF) Subjects;

Role: Co-Investigator

PI- B. Chartfield

2006 - 2008

 

Cystic Fibrosis Foundation: The EPIC Observation Study: Longitudinal Assessment of Risk Factors For and Impact of Pseudomonas aeruginosa Acquisition and Early Anti-Pseudomonal Treatment in Children with Cystic Fibrosis;

Role: Co-Investigator

PI-  B. Chartfield

2005 2006

 

Cystic Fibrosis Foundation: Effectiveness and Safety of Intermittent Antimicrobial Therapy for the Treatment of New Onset Pseudomonas aeruginosa Airway Infection in Young Patients with Cystic Fibrosis;

Role: Co-Investigator

PI- B. Chartfield

2005 – 2008

 

Cystic Fibrosis Foundation: Multi-center, Multi-national, Randomized, Placebo-Controlled Trial of Azithromycin in Subjects with Cystic Fibrosis 6-18 years old, Culture Negative for Pseudomonas aeruginosa;

Role: Co-Investigator

PI- B. Chartfield

2006 2009

 

Industry Sponsored (Wyeth): A Phase 3, Randomized, Active-Controlled, Double-Blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of 3 Lots of 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants Given With Routine Pediatric Vaccinations in the United States.;

Role: Co-Investigator

PI- C. Byington

2007 2009

 

Industry Sponsored (Medimmune): A phase 2, randomized double-blind, placebo-controlled study to evaluate a single intraveinous dose of motavizumab (MEDI-524),  a humanized enhanced potency monoclonal antibody against respiratory syncytial virus (RSV), for the treatment of children hospitalized with RSV illness.

Role: Site Principal Investigator

2007 – 2009

 

TEACHING RESPONSIBILITIES

Pediatric Infectious Diseases lectures during pediatric noon-conference to medical students, resident and fellows. Thirty to 40 participants per lecture.

 

 

Mentoring of Post-Graduate Fellows

 

Lauren Lajos, MD

Fellow, Pediatric Infectious Diseases

20212024

 

Marilyn Valentine, MD

Fellow, Pediatric Infectious Diseases

20202023

 

T. W. Jones, MD

Fellow, Pediatric Infectious Diseases

20182021

 

Nicole Pershing, MD

Fellow, Pediatric Infectious Diseases

20182021

 

Joel Howard, MD

Fellow, Pediatric Infectious Diseases

20172020

 

Sonia Mehra, MD

Fellow, Pediatric Infectious Diseases

20152018

 

Angela Vessenmeyer, MD

Fellow, Pediatric Infectious Diseases

2014 2016

 

Andrew Nuibe, MD

Fellow, Pediatric Infectious Diseases

2012 2015

 

Kristina Bayha Pierce

Master of Science in Laboratory Medicine and Biomedical Science

2014

Carly Davis, MD

Human Metapneumovirus

Fellow Infectious Diseases

20112014

 

Elizabeth Doby, MD

Rhinovirus

Fellow Infectious Diseases

2010 – 2013

 

Hannah Kirking

Pediatric Resident

Comparison of respiratory viruses (RSV, IV and hMPV)

2013

 

Liset Olarte

Pediatric Resident

S. pneumoniae infection in infants younger than 90 days

2013

 

Christopher Stockmann, MSc

Group A Streptococcus

Master in Clinical Investigation

2009 – 2011

 

Angel Herrera Guerera, MD

Fellow Infectious Diseases

Rotavirus in Utah children

2008 – 2011

 

Jeffrey Bender, MD

Fellow Infectious Diseases

Influenza and Streptococcus pneumoniae                                                       

2006-2009

 

Anne Blaschke, MD

Fellow Pediatric Infectious Diseases

Molecular Diagnosis of CNS Infections                                                       

2004-2006

 

Medical Student Research

 

Brittany McDowell

Burden and Cost of Hospitalized Parainfluenza infection in Children

2016

 

Gabriel Cortez (New Mexico State University)

Seasonality of AOM

2012

 

Gabriel Cortez (New Mexico State University)

Differences between seasonal versus pandemic (2009 H1N1) influenza

2011

 

Christina Sadler (University of Utah, MS IV)

Human Metapneumovirus                                                                                   

2008

 

Michelle Mills (University of Utah, MS IV)

Pediatric Influenza                                                                                                               

2004

 

PEER-REVIEWED JOURNAL ARTICLES

 

  1. Ekambaram M, Nabower A, Rajbhandari P, Eisenberg J, Goodrich N, Ampofo K, Gollehon NS, Martin KC, Lyden E, Snowden J. Evaluation of Discordant Results Between FilmArray Meningitis/Encephalitis Panel and Conventional Testing in Pediatric Patients: A Multisite Retrospective Cohort Study. J Pediatric Infect Dis Soc. 2022 Jan 10: PMID: 35020927

 

  1. Gladstone RA, Siira L, Brynildsrud OB, Vestrheim DF, Turner P, Clarke SC, Srifuengfung S, Ford R, Lehmann D, Egorova E, Voropaeva E, Haraldsson G, Kristinsson KG, McGee L, Breiman RF, Bentley SD, Sheppard CL, Fry NK, Corander J, Toropainen M, Steens A; Global Pneumococcal Sequencing Consortium. International links between Streptococcus pneumoniae vaccine serotype 4 sequence type (ST) 801 in Northern European shipyard outbreaks of invasive pneumococcal disease. Vaccine. 2022 Feb 11;40(7):1054-1060. doi: 10.1016/j.vaccine.2021.10.046. Epub 2022 Jan 5. PMID: 34996643 

 

  1. Deloria Knoll M, Bennett JC, Garcia Quesada M, Kagucia EW, Peterson ME, Feikin DR, Cohen AL, Hetrich MK, Yang Y, Sinkevitch JN, Ampofo K, Aukes L, Bacci S, Bigogo G, Brandileone MC, Bruce MG, Camilli R, Castilla J, Chan G, Chanto Chacón G, Ciruela P, Cook H, Corcoran M, Dagan R, Danis K, de Miguel S, De Wals P, Desmet S, Galloway Y, Georgakopoulou T, Hammitt LL, Hilty M, Ho PL, Jayasinghe S, Kellner JD, Kleynhans J, Knol MJ, Kozakova J, Kristinsson KG, Ladhani SN, Lara CS, León ME, Lepp T, Mackenzie GA, Mad'arová L, McGeer A, Mungun T, Mwenda JM, Nuorti JP, Nzoyikorera N, Oishi K, De Oliveira LH, Paragi M, Pilishvili T, Puentes R, Rafai E, Saha SK, Savrasova L, Savulescu C, Scott JA, Scott KJ, Serhan F, Setchanova LP, Sinkovec Zorko N, Skoczyńska A, Swarthout TD, Valentiner-Branth P, van der Linden M, Vestrheim DF, von Gottberg A, Yildirim I, Hayford K, The Pserenade Team. Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project. Microorganisms. 2021 Apr 2;9(4):742. doi: 10.3390/microorganisms9040742.PMID: 33918127 
  2. Garcia Quesada M, Yang Y, Bennett JC, Hayford K, Zeger SL, Feikin DR, Peterson ME, Cohen AL, Almeida SCG, Ampofo K, Ang M, Bar-Zeev N, Bruce MG, Camilli R, Chanto Chacón G, Ciruela P, Cohen C, Corcoran M, Dagan R, De Wals P, Desmet S, Diawara I, Gierke R, Guevara M, Hammitt LL, Hilty M, Ho PL, Jayasinghe S, Kleynhans J, Kristinsson KG, Ladhani SN, McGeer A, Mwenda JM, Nuorti JP, Oishi K, Ricketson LJ, Sanz JC, Savrasova L, Setchanova LP, Smith A, Valentiner-Branth P, Valenzuela MT, van der Linden M, van Sorge NM, Varon E, Winje BA, Yildirim I, Zintgraff J, Knoll MD, The Pserenade Team. Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project. Microorganisms. 2021 Apr 1;9(4):738. doi: 10.3390/microorganisms9040738.PMID: 33916227
  3. Bennett JC, Hetrich MK, Garcia Quesada M, Sinkevitch JN, Deloria Knoll M, Feikin DR, Zeger SL, Kagucia EW, Cohen AL, Ampofo K, Brandileone MC, Bruden D, Camilli R, Castilla J, Chan G, Cook H, Cornick JE, Dagan R, Dalby T, Danis K, de Miguel S, De Wals P, Desmet S, Georgakopoulou T, Gilkison C, Grgic-Vitek M, Hammitt LL, Hilty M, Ho PL, Jayasinghe S, Kellner JD, Kleynhans J, Knol MJ, Kozakova J, Kristinsson KG, Ladhani SN, MacDonald L, Mackenzie GA, Mad'arová L, McGeer A, Mereckiene J, Morfeldt E, Mungun T, Muñoz-Almagro C, Nuorti JP, Paragi M, Pilishvili T, Puentes R, Saha SK, Sahu Khan A, Savrasova L, Scott JA, Skoczyńska A, Suga S, van der Linden M, Verani JR, von Gottberg A, Winje BA, Yildirim I, Zerouali K, Hayford K, The Pserenade Team. Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project. Microorganisms. 2021 Apr 2;9(4):742. doi: 10.3390/microorganisms9040742. PMID: 33918127.
  4. Sartori LF, Zhu Y, Grijalva CG, Ampofo K, Gesteland P, Johnson J, McHenry R, Arnold DH, Pavia AT, Edwards KM, Williams DJ. Pneumonia Severity in Children: Utility of Procalcitonin in Risk Stratification. Hosp Pediatr. 2021 Mar;11(3):215-222. doi: 10.1542/hpeds.2020-001842. Epub 2021 Feb 12.PMID: 33579748
  5. Gladstone RA, Lo SW, Goater R, Yeats C, Taylor B, Hadfield J, Lees JA, Croucher NJ, van Tonder AJ, Bentley LJ, Quah FX, Blaschke AJ, Pershing NL, Byington CL, Balaji V, Hryniewicz W, Sigauque B, Ravikumar KL, Almeida SCG, Ochoa TJ, Ho PL, du Plessis M, Ndlangisa KM, Cornick JE, Kwambana-Adams B, Benisty R, Nzenze SA, Madhi SA, Hawkins PA, Pollard AJ, Everett DB, Antonio M, Dagan R, Klugman KP, von Gottberg A, Metcalf BJ, Li Y, Beall BW, McGee L, Breiman RF, Aanensen DM, Bentley SD; The Global Pneumococcal Sequencing Consortium. Visualizing variation within Global Pneumococcal Sequence Clusters (GPSCs) and country population snapshots to contextualize pneumococcal isolates. Microb Genom. 2020 May;6(5):e000357.doi: 10.1099/mgen.0.000357. Epub 2020 Apr 29. PMID: 32375991
  6. Crandall H, Kapusta A, Killpack J, Heyrend C, Nilsson K, Dickey M, Daly JA, Ampofo K, Pavia AT, Mulvey MA, Yandell M, Hulten KG, Blaschke AJ Clinical and molecular epidemiology of invasive Staphylococcus aureus infection in Utah children; continued dominance of MSSA over MRSA. PLoS One. 2020 Sep 18;15(9):e0238991. doi: 10.1371/journal.pone.0238991. PMID: 32946486 

 

  1. Howard LM, Edwards KM, Zhu Y, Williams DJ, Self WH, Jain S, Ampofo K, Pavia AT, Arnold SR, McCullers JA, Anderson EJ, Wunderink RG, Grijalva CG.Parainfluenza Virus Types 1-3 Infections Among Children and Adults Hospitalized with Community-Acquired Pneumonia. Clin Infect Dis. 2020 Jul 18:ciaa973. doi: 10.1093/cid/ciaa973. Online ahead of print.PMID: 32681645
  2. Gladstone RA, Lo SW, Goater R, Yeats C, Taylor B, Hadfield J, Lees JA, Croucher NJ, van Tonder AJ, Bentley LJ, Quah FX, Blaschke AJ, Pershing NL, Byington CL, Balaji V, Hryniewicz W, Sigauque B, Ravikumar KL, Almeida SCG, Ochoa TJ, Ho PL, du Plessis M, Ndlangisa KM, Cornick JE, Kwambana-Adams B, Benisty R, Nzenze SA, Madhi SA, Hawkins PA, Pollard AJ, Everett DB, Antonio M, Dagan R, Klugman KP, von Gottberg A, Metcalf BJ, Li Y, Beall BW, McGee L, Breiman RF, Aanensen DM, Bentley SD; The Global Pneumococcal Sequencing ConsortiumVisualizing variation within Global Pneumococcal Sequence Clusters (GPSCs) and country population snapshots to contextualize pneumococcal isolates. Microb Genom. 2020 May;6(5):e000357. doi: 10.1099/mgen.0.000357. Epub 2020 Apr 29.PMID: 32375991 
  3. Howard LM, Edwards KM, Zhu Y, Grijalva CG, Self WH, Jain S, Ampofo K, Pavia AT, Arnold SR, McCullers JA, Anderson EJ, Wunderink RG, Williams DJ. Clinical Features of Human Metapneumovirus-Associated Community-Acquired Pneumonia Hospitalizations. Clin Infect Dis. 2020 Feb3: ciaa088. PMID: 32010955
  4. Crandall H, Christiansen J, Varghese AA, Russon A, Korgenski EK, Bengtson EK, Dickey M, Killpack J, Knackstedt ED, Daly JA, Ampofo K, Pavia AT, Blaschke AJ Clinical and Molecular Epidemiology of Invasive Haemophilus influenzae Serotype a Infections in Utah Children. J Pediatric Infect Dis Soc. 2019 Dec 19:piz088. doi: 10.1093/jpids/piz088. PMID: 31858115
  5. Fritz CQ, Edwards KM, Self WH, Grijalva CG, Zhu Y, Arnold SR, McCullers JA, Ampofo K, Pavia AT, Wunderink RG, Anderson EJ, Bramley AM, Jain S, Williams DJ. Prevalence, Risk Factors, and Outcomes of Bacteremic Pneumonia in Children. Pediatrics. 2019 Jul;14 4(1). pii: e20183090. doi: 10.1542/peds.2018-3090. PMID: 31217309
  6. Blaschke AJ, McKevitt M, Ampofo K, Lewis T, Chai H, Guo Y, Dorsch J, Vanderhoof E, Rosen P, Freimann V, Korgenski EK, Toback S, Chien JW. Midturbinate Swabs Are Comparable to Nasopharyngeal Swabs for Quantitative Detection of Respiratory Syncytial Virus in Infants. J Pediatric Infect Dis Soc. 2018 Nov 21.] PMID: 30462262
  7. Frush JM, Zhu Y, Edwards KM, Grijalva CG, Thomsen IP, Self WH, Jain S, Anderson EJ, Ampofo K, Pavia AT, Arnold SR, McCullers JA, Williams DJ. Prevalence of Staphylococcus aureus and Use of Antistaphylococcal Therapy in Children Hospitalized with Pneumonia. J Hosp Med. 2018 Dec 1;13(12):848-852. PMID: 30379141
  8. Stockmann C, Olson J, Rashid J, Lubsch L, Young DC, Hersh AL, Frymoyer A, Ampofo K, Liu X, Wang Y, Sherwin CMT, Zobell JT. An Evaluation of Vancomycin Area Under the Curve Estimation Methods for Children Treated for Acute Pulmonary Exacerbations of Cystic Fibrosis Due to Methicillin-Resistant Staphylococcus aureus. J Clin Pharmacol. 2019 Feb;59(2):198-205.. PMID: 30371946
  9. Adler FR, Stockmann C, Ampofo K, Pavia AT, Byington CL. Transmission of rhinovirus in the Utah BIG-LoVE families: Consequences of age and household structure. PLoS One. 2018 Jul 25;13(7): PMID: 30044794
  10. Bozio CH, Flanders WD, Finelli L, Bramley AM, Reed C, Gandhi NR, Vidal JE, Erdman D, Levine MZ, Lindstrom S, Ampofo K, Arnold SR, Self WH, Williams DJ, Grijalva CG, Anderson EJ, McCullers JA, Edwards KM, Pavia AT, Wunderink RG, Jain S. Use of Multiple Imputation to Estimate the Proportion of Respiratory Virus Detections Among Patients Hospitalized With Community-Acquired Pneumonia. Open Forum Infect Dis. 2018 Mar 16;5(4). PMID: 29946553
  11. Bozio CH, Flanders WD, Finelli L, Bramley AM, Reed C, Gandhi NR, Vidal JE, Erdman D, Levine MZ, Lindstrom S, Ampofo K, Arnold SR, Self WH, Williams DJ, Grijalva CG, Anderson EJ, McCullers JA, Edwards KM, Pavia AT, Wunderink RG, Jain S. Use of Multiple Imputation to Estimate the Proportion of Respiratory Virus Detections Among Patients Hospitalized With Community-Acquired Pneumonia. Open Forum Infect Dis. 2018 Mar 16;5(4):ofy061. doi: 10.1093/ofid/ofy061. eCollection 2018 Apr. PMID: 29946553
  12. Edwards KM, McCullers JA, Pavia AT, Winchell JM, Schrag SJ, Hicks LA. Mycoplasma Pneumoniae among Children Hospitalized with Community-acquired Pneumonia. Clin Infect Dis. 2018 May 17. doi: 10.1093/cid/ciy419. PMID: 29788037
  13. Nolan VG, Arnold SR, Bramley AM, Ampofo K, Williams DJ, Grijalva CG, Self WH, Anderson EJ, Wunderink RG, Edwards KM, Pavia AT, Jain S, McCullers JA. The etiology and impact of co-infections in children hospitalized with community-acquired pneumonia. J Infect Dis. 2017 Dec 8. PMID: 29228381
  14. Williams DJ, Edwards KM, Self WH, Zhu Y, Arnold SR, McCullers JA, Ampofo K, Pavia AT, Anderson EJ, Hicks LA, Bramley AM, Jain S, Grijalva CG. Effectiveness of β-Lactam Monotherapy vs Macrolide Combination Therapy for Children Hospitalized With Pneumonia. JAMA Pediatr. 2017 Dec 1;171(12):1184-1191.  PMID: 29084336
  15. Lu X, Schneider E, Jain S, Bramley AM, Hymas W, Stockmann C, Ampofo K, Arnold SR, Williams DJ, Self WH, Patel A, Chappell JD, Grijalva CG, Anderson EJ, Wunderink RG, McCullers JA, Edwards KM, Pavia AT, Erdman DD. Rhinovirus Viremia in Patients Hospitalized With Community-Acquired Pneumonia. J Infect Dis. 2017 Nov 27;216(9):1104-1111. PMID: 28968668
  16. Schlaberg R, Ampofo K, Tardif KD, Stockmann C, Simmon KE, Hymas W, Flygare S, Kennedy B, Blaschke A, Eilbeck K, Yandell M, McCullers JA, Williams DJ, Edwards K, Arnold SR, Bramley A, Jain S, Pavia AT. Human Bocavirus Capsid Messenger RNA Detection in Children With Pneumonia. J Infect Dis. 2017 Sep 15;216(6):688-696. PMID: 28934425
  17. Bramley AM, Reed C, Finelli L, Self WH, Ampofo K, Arnold SR, Williams DJ, Grijalva CG, Anderson EJ, Stockmann C, Trabue C, Fakhran S, Balk R, McCullers JA, Pavia AT, Edwards KM, Wunderink RG, Jain S; Centers for Disease Control and Prevention Etiology of Pneumonia in the Community (EPIC) Study Team. Relationship Between Body Mass Index and Outcomes Among Hospitalized Patients With Community-Acquired Pneumonia. J Infect Dis. 2017 Jun 15;215(12):1873-1882. PMID: 28520948
  18. Harris AM, Bramley AM, Jain S, Arnold SR, Ampofo K, Self WH, Williams DJ, Anderson EJ, Grijalva CG, McCullers JA, Pavia AT, Wunderink RG, Edwards KM, Winchell JM, Hicks LA. Influence of Antibiotics on the Detection of Bacteria by Culture-Based and Culture-Independent Diagnostic Tests in Patients Hospitalized With Community-Acquired Pneumonia. Open Forum Infect Dis. 2017 Feb 10;4(1); PMID: 28480285
  19. Oboho IK, Bramley A, Finelli L, Fry A, Ampofo K, Arnold SR, Self WH, Williams DJ, Courtney DM, Zhu Y, Anderson EJ, Grijalva CG, McCullers JA, Wunderink RG, Pavia AT, Edwards KM, Jain S. Oseltamivir Use Among Children and Adults Hospitalized With Community-Acquired Pneumonia. Open Forum Infect Dis. 2016 Dec 27;4(1): PMID: 28480248
  20. Schlaberg R, Queen K, Simmon K, Tardif K, Stockmann C, Flygare S, Kennedy B, Voelkerding K, Bramley A, Zhang J, Eilbeck K, Yandell M, Jain S, Pavia AT, Tong S, Ampofo K. Viral Pathogen Detection by Metagenomics and Pan-Viral Group Polymerase Chain Reaction in Children With Pneumonia Lacking Identifiable Etiology. J Infect Dis. 2017 May 1;215(9):1407-1415. PMID: 28368491
  21. Stockmann C, Ampofo K, Killpack J, Williams DJ, Edwards KM, Grijalva CG, Arnold SR, McCullers JA, Anderson EJ, Wunderink RG, Self WH, Bramley A, Jain S, Pavia AT, Blaschke AJ. Procalcitonin Accurately Identifies Hospitalized Children With Low Risk of Bacterial Community-Acquired Pneumonia. J Pediatric Infect Dis Soc. 2017 Feb 3. [Epub ahead of print]. PMID: 28158460
  22. Stockmann C, Byington CL, Pavia AT, Ampofo K, Wilkes J, Korgenski EK, Hersh AL. Limited and Variable Use of Antivirals for Children Hospitalized With Influenza. JAMA Pediatr. 2017 Jan 23. [Epub ahead of print].PMID: 28114638
  23. Zhang Y, Sakthivel SK, Bramley A, Jain S, Haynes A, Chappell JD, Hymas W, Lenny N, Patel A, Qi C, Ampofo K, Arnold SR, Self WH, Williams DJ, Hillyard D, Anderson EJ, Grijalva CG, Zhu Y, Wunderink RG, Edwards KM, Pavia AT, McCullers JA, Erdman DD. Serology Enhances Molecular Diagnosis of Respiratory Virus Infections Other than Influenza in Children and Adults Hospitalized with Community-Acquired Pneumonia. J Clin Microbiol. 2016 Dec 28;55(1):79-89. PMID: 27795341
  24. Williams DJ, Zhu Y, Grijalva CG, Self WH, Harrell FE Jr, Reed C, Stockmann C, Arnold SR, Ampofo KK, Anderson EJ, Bramley AM, Wunderink RG, McCullers JA, Pavia AT, Jain S, Edwards KM. Predicting Severe Pneumonia Outcomes in Children. Pediatrics. 2016 Oct;138(4). PMID: 27688362
  25. Stockmann C, Ampofo K, Pavia AT, Blaschke AJ, Mason EO, Presson AP, Forney LJ, Byington CL. Clinical and Epidemiological Evidence of the Red Queen Hypothesis in Pneumococcal Serotype Dynamics. Clin Infect Dis. 2016 Sep 1;63(5):619-26. PMID: 2728271
  26. Flygare S, Simmon K, Miller C, Qiao Y, Kennedy B, Di Sera T, Graf EH, Tardif KD, Kapusta A, Rynearson S, Stockmann C, Queen K, Tong S, Voelkerding KV, Blaschke A, Byington CL, Jain S, Pavia A, Ampofo K, Eilbeck K, Marth G, Yandell M, Schlaberg R. Taxonomer: an interactive metagenomics analysis portal for universal pathogen detection and host mRNA expression profiling. Genome Biol. 2016 May 26;17(1):111..PMID: 27224977
  27. Diaz MH, Cross KE, Benitez AJ, Hicks LA, Kutty P, Bramley AM, Chappell JD, Hymas W, Patel A, Qi C, Williams DJ, Arnold SR, Ampofo K, Self WH, Grijalva CG, Anderson EJ, McCullers JA, Pavia AT, Wunderink RG, Edwards KM, Jain S, Winchell JM. Identification of Bacterial and Viral Codetections With Mycoplasma pneumoniae Using the TaqMan Array Card in Patients Hospitalized With Community-Acquired Pneumonia. Open Forum Infect Dis. 2016 Mar 30;3(2): PMID: 27191004
  28. Millman AJ, Finelli L, Bramley AM, Peacock G, Williams DJ, Arnold SR, Grijalva CG, Anderson EJ, McCullers JA, Ampofo K, Pavia AT, Edwards KM, Jain S. Community-Acquired Pneumonia Hospitalization among Children with Neurologic Disorders. J Pediatr. 2016 Mar 17. [Epub ahead of print]. PMID: 27017483
  29. Kendall BA, Dascomb KK, Mehta RR, Stockmann C, Mason EO, Ampofo K, Pavia AT, Byington CL.Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children. Vaccine. 2016 Jan 20;34(4):474-8. PMID: 26706276
  30. Stockmann C, Ampofo K, Pavia AT, Byington CL, Sheng X, Greene TH, Korgenski EK, Hersh AL. Comparative Effectiveness of Oral Versus Outpatient Parenteral Antibiotic Therapy for Empyema. Hosp Pediatr. 2015 Dec;5(12):605-12. PMID: 26526596
  31. Grijalva CG, Zhu Y, Williams DJ, Self WH, Ampofo K, Pavia AT, Stockmann CR, McCullers J, Arnold SR, Wunderink RG, Anderson EJ, Lindstrom S, Fry AM, Foppa IM, Finelli L, Bramley AM, Jain S, Griffin MR, Edwards KM. Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination. JAMA. 2015 Oct 5:1488-1497. doi: 10.1001/jama.2015.12160. PMID:26436611
  32. Davis CR, Stockmann C, Pavia AT, Byington CL, Blaschke AJ, Hersh AL, Thorell EA, Korgenski K, Daly J, Ampofo K. Incidence, Morbidity, and Costs of Human Metapneumovirus Infection in Hospitalized Children. J Pediatric Infect Dis Soc. 2015 May 20. PMID: 26407261
  33. Kwarteng Owusu S,  Ansong D,  Poku CKA,  Owusu RKK, Owusu MO, Addo-Yobo E,Armah G, Ampofo K. Rotavirus viremia and genotype characterization among children with rotavirus diarrhoea presenting to a teaching hospital. Arch Dis Child 2015;100:A175-A176 doi:10.1136/archdischild-2015-308599.379
  34. Diaz MH, Benitez AJ, Cross KE, Hicks LA, Kutty P, Bramley AM, Chappell JD, Hymas W, Patel A, Qi C, Williams DJ, Arnold SR, Ampofo K, Self WH, Grijalva CG, Anderson EJ, McCullers JA, Pavia AT, Wunderink RG, Edwards KM, Jain S, Winchell JM. Molecular Detection and Characterization of Mycoplasma pneumoniae Among Patients Hospitalized With Community-Acquired Pneumonia in the United States. Open Forum Infect Dis. 2015 Jul 16;2(3): PMID: 26284257
  35. Byington CL, Ampofo K, Stockmann C, Adler FR, Herbener A, Miller T, Sheng X, Blaschke AJ, Crisp R, Pavia AT. Community Surveillance of Respiratory Viruses Among Families in the Utah Better Identification of Germs-Longitudinal Viral Epidemiology (BIG-LoVE) Study. Clin Infect Dis. 2015 Aug 4. pii: civ486. [Epub ahead of print] PMID:26245665
  36. Ahn A, Edwards KM, Grijalva CG, Self WH, Zhu Y, Chappell JD, Arnold SR, McCullers JA, Ampofo K, Pavia AT, Bramley AM, Jain S, Williams DJ. Secondhand Smoke Exposure and Illness Severity among Children Hospitalized with Pneumonia. J Pediatr. 2015 Jul 28. pii: S0022-3476(15)00687-3. doi: 10.1016/j.jpeds.2015.06.049. [Epub ahead of print] PMID:26231828
  37. Self WH, Williams DJ, Zhu Y, Ampofo K, Pavia AT, Chappell JD, Hymas WC, Stockmann C, Bramley AM, Schneider E, Erdman D, Finelli L, Jain S, Edwards KM, Grijalva CG. Respiratory Viral Detection in Children and Adults: Comparing Asymptomatic Controls and Patients With Community-Acquired Pneumonia. J Infect Dis. 2015 Jul 14. pii: jiv323. [Epub ahead of print] PMID: 26180044
  38. Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, Reed C, Grijalva CG, Anderson EJ, Courtney DM, Chappell JD, Qi C, Hart EM, Carroll F, Trabue C, Donnelly HK, Williams DJ, Zhu Y, Arnold SR, Ampofo K, Waterer GW, Levine M, Lindstrom S, Winchell JM, Katz JM, Erdman D, Schneider E, Hicks LA, McCullers JA, Pavia AT, Edwards KM, Finelli L; CDC EPIC Study Team. Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med. 2015 Jul 14. [Epub ahead of print] PMID: 26172429
  39. Williams DJ, Edwards KM, Self WH, Zhu Y, Ampofo K, Pavia AT, Hersh AL, Arnold SR, McCullers JA, Hicks LA, Bramley AM, Jain S, Grijalva CG. Antibiotic Choice for Children Hospitalized With Pneumonia and Adherence to National Guidelines. Pediatrics. 2015 Jun 22. pii: peds.2014-3047. PMID:26101356
  40. Nelson RE, Stockmann C, Hersh AL, Pavia AT, Korgenksi K, Daly JA, Couturier MR, Ampofo K, Thorell EA, Doby EH, Robison JA, Blaschke AJ. Economic analysis of rapid and sensitive polymerase chain reaction testing in the emergency department for influenza infections in children. Pediatr Infect Dis J. 2015 Jun;34(6):577-82.PMID:25973935
  41. Stockmann C, Ampofo K, Pavia AT, Byington CL, Blaschke AJ, Sherwin CM, Spigarelli MG, Hersh AL. National trends in the incidence, outcomes and charges of pediatric osteoarticular infections, 1997-2012. Pediatr Infect Dis J. 2015 Jun;34(6):672-4. PMID: 25806839
  42. Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, Stockmann C, Anderson EJ, Grijalva CG, Self WH, Zhu Y, Patel A, Hymas W, Chappell JD, Kaufman RA, Kan JH, Dansie D, Lenny N, Hillyard DR, Haynes LM, Levine M, Lindstrom S, Winchell JM, Katz JM, Erdman D, Schneider E, Hicks LA, Wunderink RG, Edwards KM, Pavia AT, McCullers JA, Finelli L; CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015 Feb 26;372(9):835-45.
  43. Zobell JT, Epps KL, Young DC, Montague M, Olson J, Ampofo K, Chin MJ, Marshall BC, Dasenbrook E. Utilization of antibiotics for methicillin-resistant Staphylococcus aureus infection in cystic fibrosis. Pediatr Pulmonol. 2015 Jan 5. PMID: 25559432
  44. Stockmann C, Hillyard B, Ampofo K, Spigarelli MG, Sherwin CM. Levofloxacin inhalation solution for the treatment of chronic Pseudomonas aeruginosa infection among patients with cystic fibrosis. Expert Rev Respir Med. 2014 Nov 24:1-10. PMID: 25417708
  45. Stockmann C, Spigarelli MG, Ampofo K, Sherwin CM. Bioequivalence and Bioavailability Clinical Trials: A Status Report from the National Institutes of Health ClinicalTrials.gov Registry. J Bioequiv Availab. 2013 Nov 4;5: 244-247. PMID: 25328346
  46. Delgado-Corcoran C, Witte MK, Ampofo K, Castillo R, Bodily S, Bratton SL. The impact of human rhinovirus infection in pediatric patients undergoing heart surgery. Pediatr Cardiol. 2014 Dec;35(8):1387-94. PMID: 24939564
  47. Stockmann C, Pavia AT, Hersh AL, Spigarelli MG, Castle B, Korgenski K, Byington CL, Ampofo K. Age-Specific Patterns of Influenza Activity in Utah: Do Older School Age Children Drive the Epidemic? J Pediatric Infect Dis Soc. 2014 Jun; 3(2):163-167. PMID: 24872880
  48. Blaschke AJ, Shapiro DJ, Pavia AT, Byington CL, Ampofo K, Stockmann C, Hersh AL.A National Study of the Impact of Rapid Influenza Testing on Clinical Care in the Emergency Department. J Pediatric Infect Dis Soc. 2014 Jun;3(2):112-118. Epub 2013 Nov 13.PMID: 24872879
  49. Kamal MA, Acosta EP, Kimberlin DW, Gibiansky L, Jester P, Niranjan V, Rath B, Clinch B, Sánchez PJ, Ampofo K, Whitley R, Rayner CR. The posology of oseltamivir in infants with influenza infection using a population pharmacokinetic approach. Clin Pharmacol Ther. 2014 Sep;96(3):380-9. PMID: 24865390
  50. Stockmann C, Constance JE, Roberts JK, Olson J, Doby EH, Ampofo K, Stiers J, Spigarelli MG, Sherwin CM. Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications. Clin Pharmacokinet. 2014 May;53(5):429-54. PMID: 24595533
  51. Sherwin CM, Zobell JT, Stockmann C, McCrory BE, Wisdom M, Young DC, Olson J, Ampofo K, Spigarelli MG. Pharmacokinetic and pharmacodynamic optimisation of intravenous tobramycin dosing among children with cystic fibrosis. J Pharmacokinet Pharmacodyn. 2014 Feb;41(1):71-9. PMID: 24395072
  52. Stockmann C, Sherwin CM, Ampofo K, Spigarelli MG..Development of levofloxacin inhalation solution to treat Pseudomonas aeruginosa in patients with cystic fibrosis. Ther Adv Respir Dis. 2014 Feb;8(1):13-21. PMID: 24334337
  53. Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, Levine OS, Whitney CG, O'Brien KL, Moore MR; Serotype Replacement Study Group. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med. 2013;10(9):e1001517. PMID:24086113
  54. Young DC, Zobell JT, Stockmann C, Waters CD, Ampofo K, Sherwin CM, Spigarelli MG. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. Aminoglycosides. Pediatr Pulmonol. 2013 Nov;48(11):1047-61. PMID: 24000183
  55. Stockmann C, Ampofo K, Byington CL, Filloux F, Hersh AL, Blaschke AJ, Cowan P, Korgenski K, Mason EO, Pavia AT. Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah. Pediatrics. 2013 Sep;132(3):421-8. PMID: 23979090
  56. Stockmann C, Sherwin CM, Zobell JT, Lubsch L, Young DC, Olson J, Noyes BE, Ampofo K, Spigarelli MG. Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis. Pharmacotherapy. 2013 Dec;33(12):1288-96. PMID: 23824677
  57. Mayer-Hamblett N, Rosenfeld M, Treggiari MM, Konstan MW, Retsch-Bogart G, Morgan W, Wagener J, Gibson RL, Khan U, Emerson J, Thompson V, Elkin EP, Ramsey BW; EPIC; ESCF Investigators. Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis. Pediatr Pulmonol. 2013 Oct;48(10):943-53. PMID: 23818295
  58. Olarte L, Ampofo K, Stockmann C, Mason EO, Daly JA, Pavia AT, Byington CL. Invasive pneumococcal disease in infants younger than 90 days before and after introduction of PCV7. Pediatrics. 2013 Jul;132(1):e17-24. PMID: 23733800
  59. Stockmann C, Sherwin CM, Ampofo K, Hersh AL, Pavia AT, Byington CL, Ward RM, Spigarelli MG. Characteristics of antimicrobial studies registered in the USA through ClinicalTrials.Gov. Int J Antimicrob Agents. 2013 Aug;42(2):161-6. PMID: 23726436
  60. Guerra AH, Stockmann C, Pavia AT, Hersh AL, Thorell EA, Weng HY, Korgenski K, Byington CL,Ampofo K. Laboratory-Confirmed Rotavirus Disease in Utah Children: Clinical and Economic Impact of Rotavirus Vaccination. J Pediatric Infect Dis Soc. 2012 Dec;1(4):268-277. PMID: 23687580
  61. Blaschke AJ, Byington CL, Ampofo K, Pavia AT, Heyrend C, Rankin SC, McGowan KL, Harris MC, Shah SS. Species-specific PCR improves detection of bacterial pathogens in parapneumonic empyema compared with 16S PCR and culture. Pediatr Infect Dis J. 2013 Mar;32 (3):302-3. PMID: 23558326
  62. Zobell JT, Young DC, Waters CD, Ampofo K, Stockmann C, Sherwin CM, Spigarelli MG.Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: VI. Executive summary. Pediatr Pulmonol. 2013 Jun;48 (6):525-37. PMID: 23359557
  63. Ampofo K. Infectious disease issues in adoption of young children. Curr Opin Pediatr. 2013 Feb;25(1):78-87. PMID: 23295719
  64. Stockmann C, Ampofo K, Hersh AL, Carleton ST, Korgenski K, Sheng X, Pavia AT, Byington CL. Seasonality of acute otitis media and the role of respiratory viral activity in children. Pediatr Infect Dis J. 2013 Apr;32 (4):314-9. PMID: 23249910
  65. Kimberlin DW, Acosta EP, Prichard MN, Sánchez PJ, Ampofo K, Lang D, Ashouri N, Vanchiere JA, Abzug MJ, Abughali N, Caserta MT, Englund JA, Sood SK, Spigarelli MG, Bradley JS, Lew J, Michaels MG, Wan W, Cloud G, Jester P, Lakeman FD, Whitley RJ; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza. J Infect Dis. 2013 Mar 1;207 (5):709-20. PMID: 23230059
  66. Zobell JT, Waters CD, Young DC, Stockmann C, Ampofo K, Sherwin CM, Spigarelli MG. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillins. Pediatr Pulmonol. 2013 Feb;48 (2):107-22.   PMID: 22949297
  67. Stockmann C, Sherwin CM, Zobell JT, Young DC, Waters CD, Spigarelli MG, Ampofo K.Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: III. fluoroquinolones. Pediatr Pulmonol. 2013 Mar; 48 (3):211-20. PMID: 22949224
  68. Young DC, Zobell JT, Waters CD, Ampofo K, Stockmann C, Sherwin CM, Spigarelli MG. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: IV. colistimethate sodium. Pediatr Pulmonol. 2013 Jan; 48 (1):1-7. PMID: 22949160
  69. Zobell JT, Young DC, Waters CD, Stockmann C, Ampofo K, Sherwin CM, Spigarelli MG. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: I. aztreonam and carbapenems. Pediatr Pulmonol. 2012 Dec; 47 (12):1147-58PMID: 22911974
  70. Stockmann C, Ampofo K, Hersh AL, Blaschke AJ, Kendall BA, Korgenski K, Daly J, Hill HR, Byington CL, Pavia AT. Evolving epidemiologic characteristics of invasive group a streptococcal disease in Utah, 2002-2010. Clin Infect Dis. 2012 Aug;55(4):479-87. PMID: 22534148
  71. Ampofo K, Pavia AT, Chris S, Hersh AL, Bender JM, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Mason EO, Byington CL. The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance. Pediatr Infect Dis J. 2012 Mar;31(3):228-34. PMID: 22330164
  72. Olarte L, Ampofo K, Thorell EA, Sanderson S, Doby E, Pavia AT, Rosado H, Raoult D, Socolovschi C, Hersh AL.Bartonella vinsonii endocarditis in an adolescent with congenital heart disease. Pediatr Infect Dis J. 2012 May;31(5):531-4. PMID: 22301474
  73. Zobell JT, Stockmann C, Young DC, Cash J, McDowell BJ, Korgenski K, Sherwin CM, Spigarelli M, Chatfield BA, Ampofo K. Population pharmacokinetic and pharmacodynamic modeling of high-dose intermittent ticarcillin-clavulanate administration in pediatric cystic fibrosis patients. Clin Ther. 2011 Nov;33(11):1844-50. PMID: 22018680
  74. Ampofo K, Pavia AT, Stockmann CR, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Byington CL. Evolution of the epidemiology of pneumococcal disease among Utah children through the vaccine era. Pediatr Infect Dis J. 2011 Dec;3012):1100-3. PMID: 22005513
  75. Kendall BA, Dascomb KK, Mehta RR, Mason EO, Ampofo K, Pombo DJ, Pavia AT, Byington CL.Streptococcus pneumoniae serotypes in Utah adults at the end of the PCV7 era. Vaccine. 2011 Nov 15;29(49):9123-6. PMID: 22001280
  76. Mayer-Hamblett N, Kronmal RA, Gibson RL, Rosenfeld M, Retsch-Bogart G, Treggiari MM, Burns JL, Khan U, Ramsey BW; EPIC Investigators. Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis. Pediatr Pulmonol. 2012 Feb;47(2):125-34. PMID: 21830317
  77. Hersh AL, Herigon JC, Ampofo K, Pavia AT, Newland JG. Rapid increase in use of antiviral therapy for hospitalized children with influenza during the 2009 H1N1 epidemic. Pediatr Infect Dis J. 2011 Oct;30 (10):895-7. PMID: 21587093
  78. Zobell JT, Young DC, Waters CD, Ampofo K, Cash J, Marshall BC, Olson J, Chatfield BA. A survey of the utilization of anti-pseudomonal beta-lactam therapy in cystic fibrosis patients. Pediatr Pulmonol. 2011 Oct;46 (10):987-90. PMID: 21520438
  79. Blaschke AJ, Heyrend C, Byington CL, Obando I, Vazquez-Barba I, Doby EH, Korgenski EK, Sheng X, Poritz MA, Daly JA, Mason EO, Pavia AT, Ampofo K. Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J. 2011 Apr;30 (4):289-94. PMID: 21057372
  80. Ekstrand JJ, Herbener A, Rawlings J, Turney B, Ampofo K, Korgenski EK, Bonkowsky JL. Heightened neurologic complications in children with pandemic H1N1 influenza. Ann Neurol. 2010 Nov;68 (5):762-6. PMID: 20865762
  81. Bender JM, Ampofo K, Byington CL, Grinsell M, Korgenski K, Daly JA, Mason EO, Pavia AT. Epidemiology of Streptococcus pneumoniae-induced hemolytic uremic syndrome in Utah children. Pediatr Infect Dis J. 2010 Aug;29(8):712-6. PMID: 20661100
  82. Zobell JT, Ampofo K, Cash J, Korgenski K, Chatfield BA. High dose intermittent ticarcillin-clavulanate administration in pediatric cystic fibrosis patients. J Cyst Fibros. 2010 Jul;9(4):280-3. PMID: 20472513
  83. Ampofo K, Herbener A, Blaschke AJ, Heyrend C, Poritz M, Korgenski K, Rolfs R, Jain S, Carvalho Mda G, Pimenta FC, Daly J, Mason EO, Byington CL, Pavia AT. Association of 2009 pandemic influenza A (H1N1) infection and increased hospitalization with parapneumonic empyema in children in Utah. Pediatr Infect Dis J. 2010 Oct;29(10):905-9 PMID: 20407400
  84. Byington CL, Hulten KG, Ampofo K, Sheng X, Pavia AT, Blaschke AJ, Pettigrew M, Korgenski K, Daly J, Mason EO.